Details of the Target

General Information of Target

Target ID LDTP02691
Target Name Plastin-2 (LCP1)
Gene Name LCP1
Gene ID 3936
Synonyms
PLS2; Plastin-2; L-plastin; LC64P; Lymphocyte cytosolic protein 1; LCP-1
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MARGSVSDEEMMELREAFAKVDTDGNGYISFNELNDLFKAACLPLPGYRVREITENLMAT
GDLDQDGRISFDEFIKIFHGLKSTDVAKTFRKAINKKEGICAIGGTSEQSSVGTQHSYSE
EEKYAFVNWINKALENDPDCRHVIPMNPNTNDLFNAVGDGIVLCKMINLSVPDTIDERTI
NKKKLTPFTIQENLNLALNSASAIGCHVVNIGAEDLKEGKPYLVLGLLWQVIKIGLFADI
ELSRNEALIALLREGESLEDLMKLSPEELLLRWANYHLENAGCNKIGNFSTDIKDSKAYY
HLLEQVAPKGDEEGVPAVVIDMSGLREKDDIQRAECMLQQAERLGCRQFVTATDVVRGNP
KLNLAFIANLFNRYPALHKPENQDIDWGALEGETREERTFRNWMNSLGVNPRVNHLYSDL
SDALVIFQLYEKIKVPVDWNRVNKPPYPKLGGNMKKLENCNYAVELGKNQAKFSLVGIGG
QDLNEGNRTLTLALIWQLMRRYTLNILEEIGGGQKVNDDIIVNWVNETLREAKKSSSISS
FKDPKISTSLPVLDLIDAIQPGSINYDLLKTENLNDDEKLNNAKYAISMARKIGARVYAL
PEDLVEVNPKMVMTVFACLMGKGMKRV
Target Bioclass
Other
Subcellular location
Cytoplasm, cytoskeleton
Function Actin-binding protein. Plays a role in the activation of T-cells in response to costimulation through TCR/CD3 and CD2 or CD28. Modulates the cell surface expression of IL2RA/CD25 and CD69.
Uniprot ID
P13796
Ensemble ID
ENST00000323076.7
HGNC ID
HGNC:6528
ChEMBL ID
CHEMBL4295718

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
C32 SNV: p.A250V DBIA    Probe Info 
DU145 SNV: p.A317V DBIA    Probe Info 
HCT116 SNV: p.C283Y .
VMRCRCW Insertion: p.N136dup DBIA    Probe Info 

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 31 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
P2
 Probe Info  		10.00  LDD0449  [1]
P3
 Probe Info  		10.00  LDD0450  [1]
P8
 Probe Info  		10.00  LDD0451  [1]
A-EBA
 Probe Info  		3.23  LDD0215  [2]
TH211
 Probe Info  		Y447(12.83); Y585(8.82); Y48(5.00)  LDD0260  [3]
YN-1
 Probe Info  		100.00  LDD0444  [4]
STPyne
 Probe Info  		K82(8.83); K444(4.75); K610(7.10)  LDD2217  [5]
AZ-9
 Probe Info  		E268(10.00)  LDD2208  [6]
Probe 1
 Probe Info  		Y462(16.82)  LDD3495  [7]
JZ128-DTB
 Probe Info  		N.A.  LDD0462  [8]
BTD
 Probe Info  		C164(3.56); C42(2.54); C460(2.33); C140(0.39)  LDD1700  [9]
AHL-Pu-1
 Probe Info  		C140(2.04); C42(2.25)  LDD0169  [10]
HHS-475
 Probe Info  		Y124(0.74)  LDD0264  [11]
IPM
 Probe Info  		C101(2.62); C42(1.58)  LDD1701  [9]
HHS-465
 Probe Info  		Y124(10.00)  LDD2237  [12]
DBIA
 Probe Info  		C42(1.42)  LDD0080  [13]
N1
 Probe Info  		N.A.  LDD0245  [14]
4-Iodoacetamidophenylacetylene
 Probe Info  		C42(0.00); C336(0.00); C140(0.00); C101(0.00)  LDD0038  [15]
IA-alkyne
 Probe Info  		N.A.  LDD0032  [16]
IPIAA_H
 Probe Info  		C101(0.00); C283(0.00); C206(0.00); C336(0.00)  LDD0030  [17]
IPIAA_L
 Probe Info  		C101(0.00); C206(0.00); C283(0.00); C164(0.00)  LDD0031  [17]
Lodoacetamide azide
 Probe Info  		C42(0.00); C336(0.00); C101(0.00); C164(0.00)  LDD0037  [15]
aHNE
 Probe Info  		N.A.  LDD0001  [18]
Compound 10
 Probe Info  		C101(0.00); C283(0.00); C336(0.00); C42(0.00)  LDD2216  [19]
Compound 11
 Probe Info  		C101(0.00); C336(0.00); C42(0.00)  LDD2213  [19]
PF-06672131
 Probe Info  		C42(0.00); C101(0.00)  LDD0017  [20]
1c-yne
 Probe Info  		N.A.  LDD0228  [21]
Acrolein
 Probe Info  		C460(0.00); C140(0.00); C164(0.00)  LDD0217  [22]
Methacrolein
 Probe Info  		C460(0.00); C140(0.00); C164(0.00)  LDD0218  [22]
AOyne
 Probe Info  		7.70  LDD0443  [23]
NAIA_5
 Probe Info  		C460(0.00); C618(0.00)  LDD2223  [24]
PAL-AfBPP Probe
Click To Hide/Show 3 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
VE-P
 Probe Info  		N.A.  LDD0396  [25]
Photoindomethacin
 Probe Info  		N.A.  LDD0154  [26]
STS-1
 Probe Info  		N.A.  LDD0068  [27]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0519  1-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-2-nitroethan-1-one MDA-MB-231 C140(0.66); C336(0.72); C283(0.39)  LDD2112  [9]
 LDCM0502  1-(Cyanoacetyl)piperidine MDA-MB-231 C460(0.81); C140(0.61); C336(0.45)  LDD2095  [9]
 LDCM0537  2-Cyano-N,N-dimethylacetamide MDA-MB-231 C336(0.85)  LDD2130  [9]
 LDCM0524  2-Cyano-N-(2-morpholin-4-yl-ethyl)-acetamide MDA-MB-231 C460(1.00); C140(0.55); C336(1.38); C42(1.04)  LDD2117  [9]
 LDCM0558  2-Cyano-N-phenylacetamide MDA-MB-231 C460(1.15); C336(1.19); C42(1.11); C283(1.01)  LDD2152  [9]
 LDCM0510  3-(4-(Hydroxydiphenylmethyl)piperidin-1-yl)-3-oxopropanenitrile MDA-MB-231 C42(0.94)  LDD2103  [9]
 LDCM0539  3-(4-Isopropylpiperazin-1-yl)-3-oxopropanenitrile MDA-MB-231 C460(0.37); C140(0.57); C336(0.44); C164(0.36)  LDD2132  [9]
 LDCM0538  4-(Cyanoacetyl)morpholine MDA-MB-231 C336(0.58)  LDD2131  [9]
 LDCM0026  4SU-RNA+native RNA HEK-293T C140(2.04); C42(2.25)  LDD0169  [10]
 LDCM0545  Acetamide MDA-MB-231 C460(0.54); C140(0.98); C336(0.46); C42(0.73)  LDD2138  [9]
 LDCM0520  AKOS000195272 MDA-MB-231 C140(0.57); C336(1.00); C42(0.78); C283(0.57)  LDD2113  [9]
 LDCM0498  BS-3668 MDA-MB-231 C336(0.65); C42(0.84); C283(1.06)  LDD2091  [9]
 LDCM0108  Chloroacetamide HeLa C460(0.00); C140(0.00); C164(0.00)  LDD0222  [22]
 LDCM0213  Electrophilic fragment 2 MDA-MB-231 C42(1.57)  LDD1702  [9]
 LDCM0625  F8 Ramos C140(0.91); C42(0.55); C460(0.44); C164(0.42)  LDD2187  [28]
 LDCM0572  Fragment10 Ramos C140(0.64); C42(1.00); C460(0.26); C164(0.57)  LDD2189  [28]
 LDCM0573  Fragment11 Ramos C140(2.79); C42(0.14); C336(0.60); C164(1.38)  LDD2190  [28]
 LDCM0574  Fragment12 Ramos C140(0.70); C42(1.01); C460(0.28); C164(0.67)  LDD2191  [28]
 LDCM0575  Fragment13 Ramos C140(1.07); C42(0.95); C460(0.31); C164(1.26)  LDD2192  [28]
 LDCM0576  Fragment14 Ramos C140(1.24); C42(0.76); C460(0.46); C336(0.79)  LDD2193  [28]
 LDCM0579  Fragment20 Ramos C140(0.55); C42(1.06); C460(0.29); C164(0.56)  LDD2194  [28]
 LDCM0580  Fragment21 Ramos C140(0.96); C42(0.89); C460(0.38); C164(1.04)  LDD2195  [28]
 LDCM0582  Fragment23 Ramos C140(1.16); C42(1.67); C460(0.84); C164(2.03)  LDD2196  [28]
 LDCM0578  Fragment27 Ramos C140(1.04); C42(1.14); C460(0.62); C164(1.07)  LDD2197  [28]
 LDCM0586  Fragment28 Ramos C140(0.51); C42(0.29); C460(0.33); C336(0.85)  LDD2198  [28]
 LDCM0588  Fragment30 Ramos C140(1.42); C42(1.31); C460(0.59); C164(1.06)  LDD2199  [28]
 LDCM0589  Fragment31 Ramos C140(1.33); C42(1.62); C460(0.40); C164(1.55)  LDD2200  [28]
 LDCM0590  Fragment32 Ramos C140(0.64); C42(1.03); C460(0.62); C164(0.76)  LDD2201  [28]
 LDCM0468  Fragment33 Ramos C140(1.24); C42(0.97); C460(0.51); C164(1.20)  LDD2202  [28]
 LDCM0596  Fragment38 Ramos C140(1.40); C42(1.38); C460(0.69); C164(1.52)  LDD2203  [28]
 LDCM0566  Fragment4 Ramos C140(0.81); C42(1.38); C460(0.54); C164(0.62)  LDD2184  [28]
 LDCM0610  Fragment52 Ramos C140(1.81); C42(1.34); C460(0.40); C164(1.20)  LDD2204  [28]
 LDCM0614  Fragment56 Ramos C140(1.74); C42(1.40); C460(0.43); C164(0.88)  LDD2205  [28]
 LDCM0569  Fragment7 Ramos C140(0.76); C42(2.24); C460(0.26); C164(0.55)  LDD2186  [28]
 LDCM0571  Fragment9 Ramos C140(0.55); C42(1.02); C460(0.25); C164(0.57)  LDD2188  [28]
 LDCM0116  HHS-0101 DM93 Y124(0.74)  LDD0264  [11]
 LDCM0117  HHS-0201 DM93 Y124(0.66)  LDD0265  [11]
 LDCM0118  HHS-0301 DM93 Y124(0.70)  LDD0266  [11]
 LDCM0119  HHS-0401 DM93 Y124(0.64)  LDD0267  [11]
 LDCM0120  HHS-0701 DM93 Y124(0.76)  LDD0268  [11]
 LDCM0107  IAA HeLa C460(0.00); C140(0.00); C164(0.00)  LDD0221  [22]
 LDCM0179  JZ128 PC-3 N.A.  LDD0462  [8]
 LDCM0022  KB02 HCT 116 C42(1.42)  LDD0080  [13]
 LDCM0023  KB03 HCT 116 C42(1.66)  LDD0081  [13]
 LDCM0024  KB05 HCT 116 C42(1.04)  LDD0082  [13]
 LDCM0509  N-(4-bromo-3,5-dimethylphenyl)-2-nitroacetamide MDA-MB-231 C42(1.04); C164(1.52)  LDD2102  [9]
 LDCM0528  N-(4-bromophenyl)-2-cyano-N-phenylacetamide MDA-MB-231 C336(0.77); C42(0.87); C101(0.84)  LDD2121  [9]
 LDCM0109  NEM HeLa C164(0.00); C140(0.00)  LDD0223  [22]
 LDCM0496  Nucleophilic fragment 11a MDA-MB-231 C460(0.54); C140(1.03); C336(0.71); C42(0.73)  LDD2089  [9]
 LDCM0497  Nucleophilic fragment 11b MDA-MB-231 C336(0.76); C42(1.04)  LDD2090  [9]
 LDCM0499  Nucleophilic fragment 12b MDA-MB-231 C460(1.12)  LDD2092  [9]
 LDCM0500  Nucleophilic fragment 13a MDA-MB-231 C460(1.34); C42(1.31); C283(1.43); C164(1.19)  LDD2093  [9]
 LDCM0501  Nucleophilic fragment 13b MDA-MB-231 C460(2.39); C42(1.31)  LDD2094  [9]
 LDCM0504  Nucleophilic fragment 15a MDA-MB-231 C460(0.74); C140(0.50); C336(0.60); C42(0.61)  LDD2097  [9]
 LDCM0505  Nucleophilic fragment 15b MDA-MB-231 C460(0.62); C42(0.67)  LDD2098  [9]
 LDCM0506  Nucleophilic fragment 16a MDA-MB-231 C336(1.03); C42(1.14); C283(0.79); C101(1.24)  LDD2099  [9]
 LDCM0508  Nucleophilic fragment 17a MDA-MB-231 C460(0.84); C140(0.62); C336(0.82); C101(1.06)  LDD2101  [9]
 LDCM0511  Nucleophilic fragment 18b MDA-MB-231 C283(0.50)  LDD2104  [9]
 LDCM0512  Nucleophilic fragment 19a MDA-MB-231 C460(2.00); C140(1.07)  LDD2105  [9]
 LDCM0514  Nucleophilic fragment 20a MDA-MB-231 C42(0.87); C283(0.97); C101(0.98)  LDD2107  [9]
 LDCM0516  Nucleophilic fragment 21a MDA-MB-231 C336(0.78); C42(0.85); C283(0.97); C101(1.15)  LDD2109  [9]
 LDCM0518  Nucleophilic fragment 22a MDA-MB-231 C460(1.02); C140(0.56); C336(1.07); C42(1.13)  LDD2111  [9]
 LDCM0521  Nucleophilic fragment 23b MDA-MB-231 C460(0.55); C336(0.63); C283(0.46)  LDD2114  [9]
 LDCM0522  Nucleophilic fragment 24a MDA-MB-231 C460(0.37); C140(0.37); C336(0.50); C42(0.46)  LDD2115  [9]
 LDCM0526  Nucleophilic fragment 26a MDA-MB-231 C42(1.96); C283(2.41); C101(1.69)  LDD2119  [9]
 LDCM0527  Nucleophilic fragment 26b MDA-MB-231 C460(0.92); C336(0.87); C42(0.89); C283(0.74)  LDD2120  [9]
 LDCM0530  Nucleophilic fragment 28a MDA-MB-231 C336(1.09); C42(0.82); C283(1.11); C101(1.03)  LDD2123  [9]
 LDCM0532  Nucleophilic fragment 29a MDA-MB-231 C140(0.74); C336(1.04); C42(0.86); C283(0.90)  LDD2125  [9]
 LDCM0533  Nucleophilic fragment 29b MDA-MB-231 C42(0.60)  LDD2126  [9]
 LDCM0534  Nucleophilic fragment 30a MDA-MB-231 C460(1.07); C140(0.32); C336(1.20); C42(1.10)  LDD2127  [9]
 LDCM0535  Nucleophilic fragment 30b MDA-MB-231 C460(0.92); C42(0.99); C283(0.71); C164(1.02)  LDD2128  [9]
 LDCM0536  Nucleophilic fragment 31 MDA-MB-231 C460(1.14); C140(0.33); C336(1.28); C42(1.25)  LDD2129  [9]
 LDCM0540  Nucleophilic fragment 35 MDA-MB-231 C460(0.54); C140(0.34); C42(0.61); C101(0.98)  LDD2133  [9]
 LDCM0541  Nucleophilic fragment 36 MDA-MB-231 C140(0.33); C336(0.47); C42(0.38); C164(0.68)  LDD2134  [9]
 LDCM0542  Nucleophilic fragment 37 MDA-MB-231 C460(1.16); C140(0.83); C42(1.23); C283(1.07)  LDD2135  [9]
 LDCM0543  Nucleophilic fragment 38 MDA-MB-231 C336(1.21); C42(1.39); C283(2.33); C101(1.55)  LDD2136  [9]
 LDCM0544  Nucleophilic fragment 39 MDA-MB-231 C460(0.84); C140(0.36); C336(1.34); C42(0.90)  LDD2137  [9]
 LDCM0211  Nucleophilic fragment 3b MDA-MB-231 C164(3.56); C42(2.54); C460(2.33); C140(0.39)  LDD1700  [9]
 LDCM0546  Nucleophilic fragment 40 MDA-MB-231 C460(2.05); C336(0.97); C42(1.05); C283(1.07)  LDD2140  [9]
 LDCM0547  Nucleophilic fragment 41 MDA-MB-231 C336(0.46)  LDD2141  [9]
 LDCM0549  Nucleophilic fragment 43 MDA-MB-231 C42(0.94); C283(1.07)  LDD2143  [9]
 LDCM0550  Nucleophilic fragment 5a MDA-MB-231 C460(2.10); C140(0.52); C336(2.83); C42(2.28)  LDD2144  [9]
 LDCM0551  Nucleophilic fragment 5b MDA-MB-231 C460(0.39); C140(0.12); C42(0.38)  LDD2145  [9]
 LDCM0552  Nucleophilic fragment 6a MDA-MB-231 C460(0.83); C336(1.11); C42(0.87); C283(0.99)  LDD2146  [9]
 LDCM0553  Nucleophilic fragment 6b MDA-MB-231 C460(2.60); C42(1.66); C283(3.15); C164(3.37)  LDD2147  [9]
 LDCM0554  Nucleophilic fragment 7a MDA-MB-231 C336(0.75); C42(0.70); C283(0.44); C101(0.58)  LDD2148  [9]
 LDCM0556  Nucleophilic fragment 8a MDA-MB-231 C336(0.46); C42(0.75); C283(1.28); C101(0.59)  LDD2150  [9]
 LDCM0557  Nucleophilic fragment 8b MDA-MB-231 C42(1.41)  LDD2151  [9]
 LDCM0131  RA190 MM1.R C42(1.51); C283(1.28); C336(1.13); C101(1.03)  LDD0304  [29]
 LDCM0170  Structure8 Ramos 4.15  LDD0433  [30]

References

1 Comparison of Different Competitive Proteome Profiling Approaches in Target Identification of Covalent Inhibitors. Chembiochem. 2022 Dec 16;23(24):e202200389. doi: 10.1002/cbic.202200389. Epub 2022 Nov 22.
2 2-Ethynylbenzaldehyde-Based, Lysine-Targeting Irreversible Covalent Inhibitors for Protein Kinases and Nonkinases. J Am Chem Soc. 2023 Feb 12. doi: 10.1021/jacs.2c11595. Online ahead of print.
Mass spectrometry data entry: PXD037665
3 Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes. Chem Sci. 2021 Jan 21;12(9):3295-3307. doi: 10.1039/d0sc06623k.
4 Ynamide Electrophile for the Profiling of Ligandable Carboxyl Residues in Live Cells and the Development of New Covalent Inhibitors. J Med Chem. 2022 Aug 11;65(15):10408-10418. doi: 10.1021/acs.jmedchem.2c00272. Epub 2022 Jul 26.
5 Global profiling of lysine reactivity and ligandability in the human proteome. Nat Chem. 2017 Dec;9(12):1181-1190. doi: 10.1038/nchem.2826. Epub 2017 Jul 31.
6 2H-Azirine-Based Reagents for Chemoselective Bioconjugation at Carboxyl Residues Inside Live Cells. J Am Chem Soc. 2020 Apr 1;142(13):6051-6059. doi: 10.1021/jacs.9b12116. Epub 2020 Mar 23.
7 An Azo Coupling-Based Chemoproteomic Approach to Systematically Profile the Tyrosine Reactivity in the Human Proteome. Anal Chem. 2021 Jul 27;93(29):10334-10342. doi: 10.1021/acs.analchem.1c01935. Epub 2021 Jul 12.
8 A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification. J Am Chem Soc. 2019 Jan 9;141(1):191-203. doi: 10.1021/jacs.8b07911. Epub 2018 Dec 20.
9 Nucleophilic covalent ligand discovery for the cysteine redoxome. Nat Chem Biol. 2023 Nov;19(11):1309-1319. doi: 10.1038/s41589-023-01330-5. Epub 2023 May 29.
Mass spectrometry data entry: PXD039908 , PXD029761
10 Chemoproteomic capture of RNA binding activity in living cells. Nat Commun. 2023 Oct 7;14(1):6282. doi: 10.1038/s41467-023-41844-z.
Mass spectrometry data entry: PXD044625
11 Discovery of a Cell-Active SuTEx Ligand of Prostaglandin Reductase 2. Chembiochem. 2021 Jun 15;22(12):2134-2139. doi: 10.1002/cbic.202000879. Epub 2021 Apr 29.
12 Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat Chem Biol. 2020 Feb;16(2):150-159. doi: 10.1038/s41589-019-0404-5. Epub 2019 Nov 25.
13 Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May;39(5):630-641. doi: 10.1038/s41587-020-00778-3. Epub 2021 Jan 4.
14 Cyclopropenone, Cyclopropeniminium Ion, and Cyclopropenethione as Novel Electrophilic Warheads for Potential Target Discovery of Triple-Negative Breast Cancer. J Med Chem. 2023 Feb 23;66(4):2851-2864. doi: 10.1021/acs.jmedchem.2c01889. Epub 2023 Feb 10.
15 Enhancing Cysteine Chemoproteomic Coverage through Systematic Assessment of Click Chemistry Product Fragmentation. Anal Chem. 2022 Mar 8;94(9):3800-3810. doi: 10.1021/acs.analchem.1c04402. Epub 2022 Feb 23.
Mass spectrometry data entry: PXD028853
16 SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*. Chembiochem. 2021 May 14;22(10):1841-1851. doi: 10.1002/cbic.202000870. Epub 2021 Feb 18.
Mass spectrometry data entry: PXD023056 , PXD023059 , PXD023058 , PXD023057 , PXD023060
17 SP3-Enabled Rapid and High Coverage Chemoproteomic Identification of Cell-State-Dependent Redox-Sensitive Cysteines. Mol Cell Proteomics. 2022 Apr;21(4):100218. doi: 10.1016/j.mcpro.2022.100218. Epub 2022 Feb 25.
Mass spectrometry data entry: PXD029500 , PXD031647
18 A modification-centric assessment tool for the performance of chemoproteomic probes. Nat Chem Biol. 2022 Aug;18(8):904-912. doi: 10.1038/s41589-022-01074-8. Epub 2022 Jul 21.
Mass spectrometry data entry: PXD027758 , PXD027755 , PXD027760 , PXD027762 , PXD027756 , PXD027591 , PXD007149 , PXD030064 , PXD032392 , PXD027789 , PXD027767 , PXD027764
19 Multiplexed CuAAC Suzuki-Miyaura Labeling for Tandem Activity-Based Chemoproteomic Profiling. Anal Chem. 2021 Feb 2;93(4):2610-2618. doi: 10.1021/acs.analchem.0c04726. Epub 2021 Jan 20.
Mass spectrometry data entry: PXD022279
20 Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles. Mol Cell Proteomics. 2023 Jan;22(1):100455. doi: 10.1016/j.mcpro.2022.100455. Epub 2022 Nov 24.
Mass spectrometry data entry: PXD036569
21 Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine. Angew Chem Int Ed Engl. 2022 Jan 26;61(5):e202112107. doi: 10.1002/anie.202112107. Epub 2021 Dec 16.
22 ACR-Based Probe for the Quantitative Profiling of Histidine Reactivity in the Human Proteome. J Am Chem Soc. 2023 Mar 8;145(9):5252-5260. doi: 10.1021/jacs.2c12653. Epub 2023 Feb 27.
23 Chemoproteomic profiling of targets of lipid-derived electrophiles by bioorthogonal aminooxy probe. Redox Biol. 2017 Aug;12:712-718. doi: 10.1016/j.redox.2017.04.001. Epub 2017 Apr 5.
24 N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics. Nat Commun. 2023 Jun 15;14(1):3564. doi: 10.1038/s41467-023-39268-w.
Mass spectrometry data entry: PXD041264
25 Pharmacological Targeting of Vacuolar H(+)-ATPase via Subunit V1G Combats Multidrug-Resistant Cancer. Cell Chem Biol. 2020 Nov 19;27(11):1359-1370.e8. doi: 10.1016/j.chembiol.2020.06.011. Epub 2020 Jul 9.
26 Small Molecule Interactome Mapping by Photoaffinity Labeling Reveals Binding Site Hotspots for the NSAIDs. J Am Chem Soc. 2018 Mar 28;140(12):4259-4268. doi: 10.1021/jacs.7b11639. Epub 2018 Mar 15.
Mass spectrometry data entry: PXD007094
27 Proteome profiling reveals potential cellular targets of staurosporine using a clickable cell-permeable probe. Chem Commun (Camb). 2011 Oct 28;47(40):11306-8. doi: 10.1039/c1cc14824a. Epub 2011 Sep 16.
28 Site-specific quantitative cysteine profiling with data-independent acquisition-based mass spectrometry. Methods Enzymol. 2023;679:295-322. doi: 10.1016/bs.mie.2022.07.037. Epub 2022 Sep 7.
Mass spectrometry data entry: PXD027578
29 Physical and Functional Analysis of the Putative Rpn13 Inhibitor RA190. Cell Chem Biol. 2020 Nov 19;27(11):1371-1382.e6. doi: 10.1016/j.chembiol.2020.08.007. Epub 2020 Aug 27.
30 2-Sulfonylpyridines as Tunable, Cysteine-Reactive Electrophiles. J Am Chem Soc. 2020 May 13;142(19):8972-8979. doi: 10.1021/jacs.0c02721. Epub 2020 Apr 29.